Jennifer G Whisenant Selected Research

Jennifer G Whisenant Research Topics

Disease

20	Neoplasms (Cancer) 02/2024 - 07/2009
8	Breast Neoplasms (Breast Cancer) 01/2023 - 07/2013
4	COVID-19 08/2022 - 01/2020
3	Fatigue 02/2024 - 01/2018
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2021 - 01/2018
2	Infections 08/2022 - 12/2021
2	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 01/2017
2	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2019 - 12/2018
2	Nausea 01/2019 - 01/2018
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2018 - 01/2018
1	Thymoma (Thymic Carcinoma) 02/2024
1	Diarrhea 02/2024
1	Cancer Pain 10/2023
1	Asymptomatic Infections 08/2022
1	Adenocarcinoma 01/2022
1	Pneumonia (Pneumonitis) 01/2022
1	Brain Neoplasms (Brain Tumor) 11/2021
1	Renal Cell Carcinoma (Grawitz Tumor) 11/2020
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2020
1	Hypertension (High Blood Pressure) 01/2020
1	Lung Neoplasms (Lung Cancer) 11/2019
1	Vomiting 01/2019
1	Dehydration (Water Stress) 01/2019
1	Chromosomal Instability (Chromosome Stability) 01/2019
1	Neoplasm Metastasis (Metastasis) 10/2018
1	Neutropenia 01/2018
1	Anemia 01/2018
1	Rectal Neoplasms (Rectal Cancer) 01/2018
1	Thrombocytopenia (Thrombopenia) 01/2018
1	Lymphopenia (Lymphocytopenia) 01/2018
1	Leukopenia 01/2018
1	Triple Negative Breast Neoplasms 11/2017
1	Biliary Tract Neoplasms (Biliary Tract Cancer) 01/2017
1	Breast Diseases (Breast Disease) 07/2013

Drug/Important Bio-Agent (IBA)

6	Trastuzumab (Herceptin)FDA Link 06/2020 - 12/2014
3	Tyrosine Kinase InhibitorsIBA 02/2024 - 01/2018
3	Albumin-Bound Paclitaxel FDA Link 06/2020 - 10/2015
2	Immune Checkpoint InhibitorsIBA 02/2024 - 11/2020
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 02/2024 - 01/2018
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2024 - 01/2016
2	Alanine Transaminase (SGPT)IBA 02/2024 - 01/2018
2	Anaplastic Lymphoma KinaseIBA 11/2021 - 01/2018
2	ensartinibIBA 11/2021 - 01/2018
2	MLN 8237IBA 01/2019 - 12/2018
2	Aurora Kinase AIBA 01/2019 - 12/2018
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2018 - 01/2017
2	Gemcitabine FDA Link 01/2018 - 01/2017
2	Biomarkers (Surrogate Marker)IBA 11/2017 - 12/2014
1	Platelet-Derived Growth FactorIBA 02/2024
1	NivolumabIBA 02/2024
1	Programmed Cell Death 1 ReceptorIBA 02/2024
1	vorolanibIBA 02/2024
1	avelumabIBA 01/2022
1	Glutamine (L-Glutamine)FDA Link 01/2022
1	ProcalcitoninIBA 01/2022
1	C-Reactive ProteinIBA 01/2022
1	CrizotinibIBA 11/2021
1	pazopanib FDA Link 11/2020
1	ORALIT (ORS)IBA 01/2020
1	Circulating Tumor DNAIBA 11/2019
1	N 30IBA 01/2019
1	fluoromisonidazoleIBA 01/2019
1	PlatinumIBA 01/2019
1	1- (3- (1- methyl- 1H- pyrazol- 4- yl)- 5- oxo- 5H- benzo(4,5)cyclohepta(1,2- b)pyridin- 7- yl)- N- (pyridin- 2- ylmethyl)methanesulfonamideIBA 10/2018
1	Dasatinib (BMS 354825)FDA Link 01/2018
1	Proteins (Proteins, Gene)FDA Link 01/2018
1	STA 9090IBA 01/2018
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2018
1	Cytotoxins (Cytolysins)IBA 01/2018
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2017
1	linifanibIBA 01/2017
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2016
1	human ERBB2 proteinIBA 10/2015
1	APTIBA 07/2013
1	AmidesIBA 07/2013
1	Bovine Serum AlbuminIBA 07/2013
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 07/2009
1	Contrast MediaIBA 07/2009

Therapy/Procedure

10	Therapeutics 08/2022 - 01/2016
3	Drug Therapy (Chemotherapy) 02/2024 - 01/2017
2	Aftercare (After-Treatment) 12/2021 - 10/2015
1	Medication Reconciliation 10/2023
1	Mastectomy (Mammectomy) 01/2023
1	Nephrectomy 11/2020
1	Critical Care (Surgical Intensive Care) 01/2020
1	Neoadjuvant Therapy 07/2013